Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Harvard Business School
Medtronic
Dow
McKinsey

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: VANDETANIB


Email this page to a colleague

« Back to Dashboard

Vandetanib

CASRN: 443913-73-3

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Moodys
Mallinckrodt
Baxter
AstraZeneca